Considering cationic flocculants for use as coagulants of the invention, specific examples include, but are not limited to, about 5 to about 80% mol of DMAEA.MCQ AcAm, DMAEA.MSQ AcAm, or DMAEA.BCQ AcAm copolymer class of {HEAD ~ approximate weight average molecular weight} of {TAIL ~ about 10 million Da} 
Considering cationic flocculants for use as coagulants of the invention , specific examples include , but are not limited to , about 5 to about 80 % mol of DMAEA.MCQ AcAm , DMAEA.MSQ AcAm , or DMAEA.BCQ AcAm copolymer class of { HEAD ~ approximate weight average molecular weight } of { TAIL ~ about 10 million Da }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL